课题基金 / 基金详情

Task Order 8 - Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy

Task Order 8 - Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy
任务令 8 - 正在开发的抗癌治疗药物的非临床毒理学研究
批准号：
8947142
负责人：
ALEXANDER LYUBIMOV
金额：
$0.05万
依托单位：
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
项目状态：
已结题
起止时间：
2011-07-01 至 2016-06-30
来源：
https://reporter.nih.gov/project-details/8947142
关键词：
AwardContractsDevelopmentGovernmentInvestigationMalignant NeoplasmsOrganPharmaceutical PreparationsProcessTestingToxic effectToxicologyanti-cancer therapeuticanticancer activitycancer therapyresearch clinical testing

项目摘要

项目成果

ALEXANDER LYUBIMOV的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The test agent is being considered for development as an anticancer therapeutic. The objective of this task was to characterize the target organ toxicities of an investigative agent that might move forward to clinical testing for anticancer activity. The information obtained from this investigation was used to identify drugs with the potential to treat cancer. This Task was terminated for the convenience of the Government.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF SUPPORT FOR HPV16L1/RG1 CHIMERIC VIRUS-LIKE PARTICLE VACCINE CLINICAL DEVELOPMENT TASKS 1&2 PP: 9/25/2015 TO 9/24/2018
SUPPORT FOR HPV16L1/RG1 CHIMERIC VIRUS-LIKE PARTICLE VACCINE CLINICAL DEVELOPMENT TASKS 1&2
IGF::OT::IGF CONTRACT ORIENTATION AND KICKOFF MEETING 9/30/15 TO 12/31/2015
Task Order 7 - Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy
海外基金